The Medford Providence Cancer Center is unveiling its new high-dose-rate (HDR) suite for patients this week for brachytherapy ...

The FDA has recently removed its “black box” warning from several estrogen-containing hormone therapy (HT) products used to treat menopause symptoms. Shannon Horning/ SciTech Editor ...

Life expectancy "was significantly shorter", particularly among those with severe learning disability or Down's syndrome, and most died within four years of diagnosis, compared with nine years in the ...

Physicians who treat women applauded parts of the decision but said they worry that the benefits of hormones might be ...

The Women's Cancer Resource Center, a nearly 40-year-old organization dedicated to helping patients in Contra Costa and ...

Studies of germline genetic testing programs provide a snapshot of challenges at academic and community practices at the NSGC annual meeting.

People in England with a learning disability have a higher risk of cancer, especially before age 50, according to a study by ...

Study finds GLP-1 drugs may reduce risk of more than a dozen cancers, offering hope in Louisiana where obesity-related cancer ...

While high BMI is a well-established risk factor for these cancers, the global, regional, and national burden attributable to high BMI remains underexplored. To address this, the researchers ...

Advancement of ACR-368 in registrational-intent Phase 2b trial for the treatment of patients with endometrial cancerPreparing for initial ...

Scientists have known that obesity and metabolic dysfunction can make cancers more aggressive. Tumors thrive in bodies ...